Weekly Digest – August 2025 Weekly Digest – August 2025 19 August 2025: Henlius licenses Phase 3 innovative HER2 ADC from GeneQuantum Henlius has licensed exclusive development and commercialization rights for GeneQuantum’s HER2-targeted ADC GQ1005 in China and selected overseas […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id